The immunochemical mechanisms involved in penicillin allergy have been the subject of numerous investigations during the past 10 years. Considerable progress in understanding how patients become sensitized to penicillin has been made since the publications by Levine (1960) and Weck and Eisen (1960) on various antigenic determinants involved in contact hypersensitivity to penicillin as well as the immunological properties of penicillanic acid, an antigenic derivative of penicillin. Also noteworthy have been the independent investigations of Levine and Ovary (1961) , Parker, Weck, Kern, and Eisen (1962a) , Parker, Shapiro, Kern, and Eisen (1962c) , and in establishing the penicilloyl group as the major antigenic determinant involved in hypersensitivity to penicillin. These investigators have shown that rabbits immunized with penicillin form anti-penicilloyl antibodies, which are detectable by precipitation, passive cutaneous anaphylaxis, and haemagglutination. Levine and Ovary (1961) reported specific skin reactions to the intradermal injections of penicilloyl-human gamma globulin conjugate in three out of six patients with histories of penicillin allergy. The specificity of these skin reactions was confirmed by their inhibition with an excess of penicilloyl-epsilonaminocaproate. Parker and others (1962c) , Weck (1962b) , and Weck and Blum (1963) shortly thereafter reported similar results, using penicilloyl-polylysine conjugates as the test material in a large number of patients.
Patients studied
The present, prospective study was conducted in a large venereal disease clinic population that was frequently exposed to therapeutic penicillin, and in which a known adverse reaction rate to therapeutic penicillin was available. All 
Results
When a skin test with PPL was performed, a positive reaction to the reagent occurred in 358 of 4,677 (7 7 per cent.) of the patients who had tolerated previous penicillin, in 41 of 124 (33 1 per cent.) who gave a history of sensitivity to penicillin, and in 22 of 660 (3 3 per cent.) who had no known history of penicillin or other therapy (Table I) . These results are in agreement with those reported by Simpson (1963) , Rytel, Klion, Arlander, and Miller (1963) , VanArsdel, Tobe, and Pasnick (1963), Brown, Price, and Moore (1964) , and Levine and Price (1964) .
Over 90 per cent. of patients in Group I were given penicillin (Table II) Adverse Reactions to PPL Penicilloyl-polylysine is not completely incapable of producing adverse reactions (Resnik and Shelley, 1966; Ettinger and Kaye, 1964) . Of our 5,461 patients who received PPL intradermally (Table III) , five developed systemic but not life-threatening reactions.
One patient showed marked erythema and oedema of the forearm around the skin test site 40 minutes after being tested; three patients developed generalized urticaria, 15, 25, and 30 minutes after receiving PPL; and one patient developed a generalized papulosquamous eruption which was delayed for 48 hours. Four of these five reactions to the test preparation occurred in patients who gave a history of penicillin hypersensitivity.
Discussion
The penicilloyl-polylysine used in this study appears to be relatively safe in that it did not per se produce any life-threatening reactions. Extensive experience proved it to produce very few ambiguous responses. During the study, the rate of adverse reactions to therapeutic penicillin was reduced to about 041 per cent., a decrease from 3 5 per cent. before the study period.
It was not considered proper to challenge with penicillin those patients whose PPL skin responses were strongly positive. Consequently, the study only indirectly corroborates previously published reports correlating positive skin tests with clinical penicillin allergy. L'intra-dermo reaction A la penicilloyl-polylysine dans 1'estimation de la sensibilisation a la p6nicilline SOMMAIRE 5.461 epreuvres intra-dermiques pour la recherche de la sensibilisation a la penicilline furent effectuees avec une nouvelle demi-molecule de penicilloyl combinee avec la polylysine. Cette preparation a donne des reponses cutanees plus franches que les preparations precedentes (0,7 pour cent de resultats ambigus de l'epreuve intradermique contre 46,6 pour cent avec les preparations anterieures). On a observe 5 incidents: 4 parmi les 124 malades dans les ant&cedents desquels etait mentionne un traitement a la penicilline et une sensibilisation et 1 chez un malade qui avait recu anterieurement de la penicilline sans ennui. La reponse cutanee au produit teste a et compar&e avec des ant&cedents d'incidents a la penicilline et avec l'effet d'un nouveau traitement a la penicilline. Pendant le cours de cette etude, le taux des incidents au traitement penicilline ne depassa pas 0,1 pour cent environ.
